Metacrine, Inc.·4

Mar 24, 12:35 PM ET

Klassen Preston 4

4 · Metacrine, Inc. · Filed Mar 24, 2023

Insider Transaction Report

Form 4
Period: 2023-03-23
Klassen Preston
DirectorPresident & CEO
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-03-23842,2110 total
    Exercise: $0.47Exp: 2032-02-26Common Stock (842,211 underlying)
  • Award

    Common Stock

    2023-03-23$0.47/sh842,211$395,8391,384,116 total
Footnotes (1)
  • [F1]Fully vested

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION